JP2023552862A5 - - Google Patents
Info
- Publication number
- JP2023552862A5 JP2023552862A5 JP2023535824A JP2023535824A JP2023552862A5 JP 2023552862 A5 JP2023552862 A5 JP 2023552862A5 JP 2023535824 A JP2023535824 A JP 2023535824A JP 2023535824 A JP2023535824 A JP 2023535824A JP 2023552862 A5 JP2023552862 A5 JP 2023552862A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- pharmaceutically acceptable
- acceptable salt
- compound according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063125671P | 2020-12-15 | 2020-12-15 | |
| US63/125,671 | 2020-12-15 | ||
| PCT/IB2021/061645 WO2022130175A1 (en) | 2020-12-15 | 2021-12-13 | Pyrido[2,3-d]imidazole derivatives and their use as inhibitors of itk for the teatment of skin disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023552862A JP2023552862A (ja) | 2023-12-19 |
| JP2023552862A5 true JP2023552862A5 (enExample) | 2024-11-06 |
Family
ID=78957649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023535824A Pending JP2023552862A (ja) | 2020-12-15 | 2021-12-13 | ピリド［２，３－ｄ］イミダゾール誘導体、および皮膚疾患の処置のためのｉｔｋの阻害剤としてのそれらの使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240124439A1 (enExample) |
| EP (1) | EP4263538A1 (enExample) |
| JP (1) | JP2023552862A (enExample) |
| CA (1) | CA3205023A1 (enExample) |
| WO (1) | WO2022130175A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3205020A1 (en) * | 2020-12-15 | 2022-06-23 | Pfizer Inc. | Benzimidazole derivatives and their use as inhibitors of itk for the treatment of skin disease |
| WO2024123175A1 (en) | 2022-12-06 | 2024-06-13 | Erasmus University Medical Center Rotterdam | Compositions for treating immune checkpoint blockade therapy resistant cancers |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2287971T3 (es) | 1997-08-11 | 2007-12-16 | Pfizer Products Inc. | Dispersiones farmaceuticas solidas con biodisponibilidad incrementada. |
| BR0213562A (pt) * | 2001-10-26 | 2004-08-31 | Aventis Pharma Inc | Benzimidazóis e análogos e seu uso como inibidores de cinases de proteìna |
| SE0202464D0 (sv) * | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | Use of compounds |
| US8299070B2 (en) * | 2009-11-25 | 2012-10-30 | Japan Tobacco Inc. | Indole compounds and pharmaceutical use thereof |
| WO2013026021A2 (en) * | 2011-08-18 | 2013-02-21 | Buck Institute For Research On Aging | Trka as a target for inhibiting app cleavage and/or progression of alzheimer's disease |
| WO2013026201A1 (zh) * | 2011-08-24 | 2013-02-28 | 厦门硅田系统工程有限公司 | 新型rfid标签微能量采集控制装置 |
| WO2014041518A1 (en) * | 2012-09-14 | 2014-03-20 | Glenmark Pharmaceuticals S.A. | Thienopyrrole derivatives as itk inhibitors |
| WO2016010108A1 (ja) * | 2014-07-18 | 2016-01-21 | 塩野義製薬株式会社 | 含窒素複素環誘導体およびそれらを含有する医薬組成物 |
-
2021
- 2021-12-13 EP EP21827674.9A patent/EP4263538A1/en active Pending
- 2021-12-13 US US18/257,195 patent/US20240124439A1/en active Pending
- 2021-12-13 CA CA3205023A patent/CA3205023A1/en active Pending
- 2021-12-13 WO PCT/IB2021/061645 patent/WO2022130175A1/en not_active Ceased
- 2021-12-13 JP JP2023535824A patent/JP2023552862A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277183B2 (en) | Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation | |
| JP2016505512A5 (enExample) | ||
| JP2021534124A5 (enExample) | ||
| JP2016538313A5 (enExample) | ||
| JP2011500758A5 (enExample) | ||
| JP2020507589A5 (enExample) | ||
| JP2018524390A5 (enExample) | ||
| JP2013528600A5 (enExample) | ||
| JP2019500387A5 (enExample) | ||
| JP2015505296A5 (enExample) | ||
| JP2014511892A5 (enExample) | ||
| JP2018514544A5 (enExample) | ||
| JP2016506962A5 (enExample) | ||
| RU2014105624A (ru) | Соединения индазола, способ их применения и фармацевтическая композиция | |
| JP2014506907A5 (enExample) | ||
| JP2012513416A5 (enExample) | ||
| JP2014528464A5 (enExample) | ||
| JP2011509309A5 (enExample) | ||
| JP2017531619A5 (enExample) | ||
| JP2013542261A5 (enExample) | ||
| JP2023552862A5 (enExample) | ||
| JP2019501879A5 (enExample) | ||
| JP2013525356A5 (enExample) | ||
| JP2013518036A5 (enExample) | ||
| JP2019529460A5 (enExample) |